<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">CJC Open</journal-id><journal-id journal-id-type="iso-abbrev">CJC Open</journal-id><journal-title-group><journal-title>CJC Open</journal-title></journal-title-group><issn pub-type="epub">2589-790X</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11681350</article-id><article-id pub-id-type="pii">S2589-790X(24)00381-0</article-id><article-id pub-id-type="doi">10.1016/j.cjco.2024.09.001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Valvular Heart Disease</subject><subj-group><subject>Systematic Review/Meta-analysis</subject></subj-group></subj-group></article-categories><title-group><article-title>Thrombus on Mitral Annular Calcification: A Systematic Review of Management and Outcomes</article-title></title-group><contrib-group><contrib contrib-type="author" id="au1"><name><surname>Cintosun</surname><given-names>Amber</given-names></name><degrees>MD, HBSc</degrees><ext-link ext-link-type="uri" xlink:href="https://www.twitter.com/amber_cintosun">@amber_cintosun</ext-link><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="au2"><name><surname>Belzile</surname><given-names>David</given-names></name><degrees>MD</degrees><ext-link ext-link-type="uri" xlink:href="https://www.twitter.com/DavidBelzile">@DavidBelzile</ext-link><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au3"><name><surname>Sooriyakanthan</surname><given-names>Maala</given-names></name><degrees>RDCS, BSc</degrees><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="au4"><name><surname>Orchanian-Cheff</surname><given-names>Ani</given-names></name><degrees>MISt</degrees><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author" id="au5"><name><surname>Tsang</surname><given-names>Wendy</given-names></name><degrees>MD, SM</degrees><email>wendy.tsang@uhn.ca</email><ext-link ext-link-type="uri" xlink:href="https://www.twitter.com/heartdocWendyT">@heartdocWendyT</ext-link><xref rid="aff2" ref-type="aff">b</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><aff id="aff1"><label>a</label>Department of Medicine, University of Toronto, Toronto, Ontario, Canada</aff><aff id="aff2"><label>b</label>Division of Cardiology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada</aff><aff id="aff3"><label>c</label>Library and Information Services, University Health Network, Toronto, Ontario, Canada</aff></contrib-group><author-notes><corresp id="cor1"><label>&#x02217;</label>Corresponding author: Wendy Tsang, MD, SM, 200 Elizabeth St, 4N-488, Toronto, Ontario M5G 2C4, Canada. Tel.: +1-416-340-4397; fax: +1-416-340-3640. <email>wendy.tsang@uhn.ca</email><ext-link ext-link-type="uri" xlink:href="https://www.twitter.com/heartdocWendyT">@heartdocWendyT</ext-link></corresp></author-notes><pub-date pub-type="pmc-release"><day>17</day><month>9</month><year>2024</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>12</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>9</month><year>2024</year></pub-date><volume>6</volume><issue>12</issue><fpage>1538</fpage><lpage>1548</lpage><history><date date-type="received"><day>29</day><month>5</month><year>2024</year></date><date date-type="accepted"><day>6</day><month>9</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2024 The Authors</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract id="abs0010"><sec><title>Background</title><p>Mitral annular calcification (MAC) is a common chronic degenerative process of the mitral valve. Thrombus formation on MAC is a rare complication that likely contributes to the increased risk of thromboembolic events. Outcomes and management strategies for this condition are unknown. The aim of this study was to perform a systematic review to describe the management and outcomes of patients who have thrombus on MAC.</p></sec><sec><title>Methods</title><p>The MEDLINE, Embase, and Cochrane databases were searched. Patients with a prior mitral valve intervention or prosthesis were excluded. The primary outcomes were treatment, mortality, and thromboembolic events.</p></sec><sec><title>Results</title><p>Fifteen studies, with a total of 22 cases (patients aged 69.1 &#x000b1; 14.8 years; n&#x000a0;= 18 [82%] female) were included. Most patients presented with stroke or a transient ischemic event (n&#x000a0;= 15; 68%) or myocardial infarction (n&#x000a0;= 4; 18%). All patients were diagnosed with either transthoracic (n&#x000a0;= 18; 82%) or transesophageal (n&#x000a0;= 4; 18%) echocardiography. Seventeen patients (77%) were treated with anticoagulation therapy alone, and 5 (23%) required surgery. The most common surgical indication was prevention of recurrent embolization (n&#x000a0;= 3; 14%). No mortality was reported. Six patients (27%) had thromboembolic events after diagnosis. For those treated with anticoagulation therapy alone, 5 (23%) had persistent thrombus with or without embolization.</p></sec><sec><title>Conclusions</title><p>In this systematic review, patients with MAC who present with a thromboembolic event require careful echocardiographic assessment of the MAC, to exclude the presence of thrombus. Although most patients can be managed with anticoagulation therapy alone, a significant number will require surgery. Persistent thrombus, despite anticoagulation therapy, and recurrent embolization are common. Larger studies are needed to elucidate what constitutes the optimal long-term care for these patients.</p></sec></abstract><trans-abstract xml:lang="fr"><title>R&#x000e9;sum&#x000e9;</title><sec><title>Contexte</title><p>La calcification de l&#x02019;anneau mitral supportant la valve mitrale est un processus d&#x000e9;g&#x000e9;n&#x000e9;ratif chronique courant. La formation d&#x02019;un thrombus sur l&#x02019;anneau mitral calcifi&#x000e9; est une complication rare qui contribue vraisemblablement &#x000e0; une hausse du risque d'&#x000e9;v&#x000e9;nements thromboemboliques. L&#x02019;issue et les strat&#x000e9;gies de prise en charge de cette affection sont inconnues. Cette &#x000e9;tude visait &#x000e0; r&#x000e9;aliser une revue syst&#x000e9;matique afin de d&#x000e9;crire la prise en charge et les r&#x000e9;sultats th&#x000e9;rapeutiques des patients pr&#x000e9;sentant un thrombus sur l&#x02019;anneau mitral calcifi&#x000e9;.</p></sec><sec><title>M&#x000e9;thodologie</title><p>Nous avons proc&#x000e9;d&#x000e9; &#x000e0; une recherche dans les bases de donn&#x000e9;es MEDLINE, Embase et Cochrane. Les patients ayant subi une intervention valvulaire mitrale ou porteurs d&#x02019;une proth&#x000e8;se valvulaire mitrale &#x000e9;taient exclus. Les principaux param&#x000e8;tres d&#x02019;&#x000e9;valuation &#x000e9;taient le type de traitement, la mortalit&#x000e9; et la survenue d'&#x000e9;v&#x000e9;nements thromboemboliques.</p></sec><sec><title>R&#x000e9;sultats</title><p>Quinze &#x000e9;tudes, regroupant au total 22 cas (patients &#x000e2;g&#x000e9;s de 69,1 &#x000b1; 14,8 ans; n&#x000a0;= 18 [82 %] de femmes), ont &#x000e9;t&#x000e9; incluses dans l&#x02019;analyse. La plupart des patients avaient subi un accident vasculaire c&#x000e9;r&#x000e9;bral et/ou un accident isch&#x000e9;mique transitoire (n&#x000a0;= 15; 68 %), ou un infarctus du myocarde (n&#x000a0;= 4; 18 %). Dans tous les cas, le diagnostic a &#x000e9;t&#x000e9; pos&#x000e9; &#x000e0; l&#x02019;aide de l&#x02019;&#x000e9;chocardiographie transthoracique (n&#x000a0;= 18; 82 %) ou trans&#x00153;sophagienne (n&#x000a0;= 4; 18 %). Dix-sept patients (77&#x000a0;%) ont re&#x000e7;u une anticoaguloth&#x000e9;rapie en monoth&#x000e9;rapie, et 5 (23 %) ont d&#x000fb; subir une intervention chirurgicale. Dans la plupart des cas, le recours &#x000e0; la chirurgie visait &#x000e0; pr&#x000e9;venir une nouvelle embolie (n&#x000a0;= 3; 14&#x000a0;%). Aucun d&#x000e9;c&#x000e8;s n&#x02019;a &#x000e9;t&#x000e9; signal&#x000e9;. Apr&#x000e8;s le diagnostic, un &#x000e9;v&#x000e9;nement thromboembolique a &#x000e9;t&#x000e9; observ&#x000e9; chez 6 patients (27 %). Parmi les patients ayant re&#x000e7;u des anticoagulants en monoth&#x000e9;rapie, on a observ&#x000e9; la r&#x000e9;currence du thrombus, avec ou sans embolie, chez 5 (23 %) d&#x02019;entre eux.</p></sec><sec><title>Conclusions</title><p>Selon cette revue syst&#x000e9;matique, les patients qui pr&#x000e9;sentent un &#x000e9;v&#x000e9;nement thromboembolique et dont l&#x02019;anneau mitral est calcifi&#x000e9; doivent faire l&#x02019;objet d&#x02019;une &#x000e9;valuation &#x000e9;chocardiographique attentive de la calcification de l&#x02019;anneau mitral afin d&#x02019;&#x000e9;carter la pr&#x000e9;sence d&#x02019;un thrombus. Bien que dans la plupart des cas, l&#x02019;administration d&#x02019;anticoagulants en monoth&#x000e9;rapie soit suffisante, un nombre important de patients devront subir une intervention chirurgicale. La persistance d&#x02019;un thrombus, malgr&#x000e9; l'anticoaguloth&#x000e9;rapie, et la r&#x000e9;currence d&#x02019;embolisation sont fr&#x000e9;quentes. Des &#x000e9;tudes de plus vaste envergure sont requises pour d&#x000e9;terminer les soins de longue dur&#x000e9;e optimaux pour ces patients.</p></sec></trans-abstract></article-meta></front><body><p id="p0010">Mitral annular calcification (MAC) is a common, chronic, degenerative, noninflammatory process involving the mitral valve annulus that results in its progressive calcification. MAC often is diagnosed incidentally on imaging studies.<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref>, <xref rid="bib3" ref-type="bibr">3</xref> The estimated prevalence of MAC ranges from 5% to 42%, with a higher prevalence in older age groups and women.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="bib4" ref-type="bibr">4</xref>, <xref rid="bib5" ref-type="bibr">5</xref>, <xref rid="bib6" ref-type="bibr">6</xref>, <xref rid="bib7" ref-type="bibr">7</xref>, <xref rid="bib8" ref-type="bibr">8</xref>, <xref rid="bib9" ref-type="bibr">9</xref>, <xref rid="bib10" ref-type="bibr">10</xref> The presence of MAC is associated with increased rates of cardiovascular and all-cause mortality, as well as cardiac and extracardiac morbidity.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref><sup>,</sup><xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib13" ref-type="bibr">13</xref>, <xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib15" ref-type="bibr">15</xref>, <xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib17" ref-type="bibr">17</xref>, <xref rid="bib18" ref-type="bibr">18</xref> Increasingly, MAC is being recognized as a significant risk factor for cerebrovascular accidents.<xref rid="bib19" ref-type="bibr">19</xref>, <xref rid="bib20" ref-type="bibr">20</xref>, <xref rid="bib21" ref-type="bibr">21</xref>, <xref rid="bib22" ref-type="bibr">22</xref> The presence of MAC alone has been reported to be associated with a 2- to 3-fold increase in the risk of stroke.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="bib21" ref-type="bibr"><sup>21</sup></xref></p><p id="p0015">Multiple mechanisms have been proposed for the link between MAC and ischemic stroke, including MAC&#x02019;s known association with increased rates of atrial fibrillation and atherosclerosis, and the embolization of calcific or caseous material on MAC.<xref rid="bib23" ref-type="bibr">23</xref>, <xref rid="bib24" ref-type="bibr">24</xref>, <xref rid="bib25" ref-type="bibr">25</xref>, <xref rid="bib26" ref-type="bibr">26</xref>, <xref rid="bib27" ref-type="bibr">27</xref>, <xref rid="bib28" ref-type="bibr">28</xref>, <xref rid="bib29" ref-type="bibr">29</xref>, <xref rid="bib30" ref-type="bibr">30</xref> Thrombus formation on MAC (<xref rid="fig1" ref-type="fig">Fig.&#x000a0;1</xref>) has been described in several case reports, and it may represent a rare mechanism for MAC&#x02019;s association with stroke.<xref rid="bib31" ref-type="bibr">31</xref>, <xref rid="bib32" ref-type="bibr">32</xref>, <xref rid="bib33" ref-type="bibr">33</xref> However, the outcomes and current management strategies for MAC thrombus are poorly understood. The aim of the current study was to perform a systematic review, to describe the management and outcomes of patients with thrombus on MAC.<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Composite image of cases with mitral annular calcification (MAC) and MAC thrombus. (<bold>A</bold>) Transthoracic parasternal short-axis view of the left ventricle (LV) at the level of the mitral valve, demonstrating moderate-to-severe posterior MAC); (<bold>B</bold>) transthoracic apical 4-chamber view demonstrating a 17 x 13 mm thrombus on the atrial side of the MAC. (<bold>C</bold>) 3-dimensional transesophageal echocardiogram of the mitral valve as visualized from the left atrial (LA) perspective, demonstrating the thrombus on the lateral side of the MAC. (<bold>D</bold>) Computed tomography demonstrating moderate-to-severe MAC and thrombus. MVL, mitral valve leaflet.</p></caption><graphic xlink:href="gr1"/></fig></p><sec id="sec1"><title>Methods</title><p id="p0020">This study protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO 2022 CRD42022299281)<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref> and was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref></p><sec id="sec1.1"><title>Search strategy</title><p id="p0025">A comprehensive search was performed in MEDLINE, Embase, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials (<xref rid="appsec1" ref-type="sec">Supplemental Appendix S1</xref>). When available, a combination of both controlled vocabulary terms, and text words (medical subject headings [MesH] and keywords) related to mitral annulus, calcification, and thrombus, were used in the subject component blocks. The search was performed for studies published from inception of the database to December 2021, and was limited to studies on humans. No language restriction was applied. No other limits were applied. Additional studies were identified by searching the article reference lists.</p></sec><sec id="sec1.2"><title>Study selection</title><p id="p0030">Inclusion criteria were all prospective and retrospective studies conducted in humans who had thrombus attached to MAC. MAC was defined as the accumulation of calcium along the mitral valve annulus seen on imaging studies. MAC thrombus was defined as a discrete mobile mass with characteristic imaging (computed tomography, cardiac magnetic resonance imaging, transesophageal echocardiography [TEE]) or pathology features consistent with thrombus attached to the calcified mitral annulus. Cases also were included if resolution occurred without evidence of embolization with therapeutic anticoagulation. If more than one publication was found that presented the same patient data, the most-recent study was included. Exclusion criteria included the following: study of nonhumans; patients having an artificial mitral valve, prior mitral valve intervention, rheumatic valvular disease, or calcified amorphous tumuor; and publication before 1985 due to the absence of reliable echocardiographic data for timepoints prior to this date.</p></sec><sec id="sec1.3"><title>Outcomes</title><p id="p0035">Our primary outcomes of interest were death, thromboembolic events (including stroke and myocardial infarction), and the need for cardiac surgery after the diagnosis of MAC with thrombus. Our secondary outcome of interest was recurrence of MAC thrombus.</p></sec><sec id="sec1.4"><title>Data extraction and quality evaluation</title><p id="p0040">Two investigators (A.C. and D.B.) independently screened records for inclusion using Covidence systematic review software (Veritas Health Innovation, Melbourne, Australia). Each of these researchers was blinded to the other&#x02019;s decisions. Disagreements were resolved by consensus between the 2 investigators, or by arbitration by a third investigator (W.T.) if the former method was unsuccessful. Extracted data included the following: patient characteristics (age, sex, ethnicity, comorbidities, presence of hypercoagulability); presentation; potential etiology; modality of diagnosis (eg, echocardiogram, computed tomography scan); location of MAC thrombus (atrial vs ventricular); location of thrombus attachment to the valve with MAC (leaflet, annulus, etc.); thrombus size; treatments for MAC thrombus; cardiac events; cardiac intervention; thromboembolic events; in-hospital death; follow-up (if any); and timeline.</p><p id="p0045">Quality assessment of the included studies was performed using a modified version of Murad et&#x000a0;al.&#x02019;s approach to methodological quality and synthesis of case series and case reports (<xref rid="appsec1" ref-type="sec">Supplemental Table&#x000a0;S1</xref>).<xref rid="bib36" ref-type="bibr"><sup>36</sup></xref> Risk of bias was assessed based on the following 4 key components: (i) patient selection (ie, whether the patient selected represented the whole experience of the investigators); (ii) ascertainment (ie, exposure and/or outcomes being adequately ascertained); (iii) causality (ie, potential alternative causes were sufficiently investigated and follow-up duration was long enough for the outcome to be able to occur); and (iv) reporting (ie, sufficient details to allow practitioners to make inferences related to their own practice). The causality component was modified to exclude the dose&#x02013;response effect and the challenge&#x02013;rechallenge phenomenon criteria as they are not relevant to MAC thrombus management. Each item was scored as &#x0201c;yes&#x0201d; or &#x0201c;no&#x0201d; (1 point per item, for a maximum score of 6 points), and the overall methodological quality and/or risk-of-bias level was rated as low, moderate, or high.</p></sec><sec id="sec1.5"><title>Data synthesis and analysis</title><p id="p0050">We used the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines to report our findings.<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> Continuous variables were summarized using medians and interquartile ranges. Categorical variables were reported as proportions.</p></sec></sec><sec id="sec2"><title>Results</title><sec id="sec2.1"><title>Study selection</title><p id="p0055">The literature search approach, review process, and reasons for study exclusion are presented in <xref rid="fig2" ref-type="fig">Figure&#x000a0;2</xref>. Characteristics of the 15 included studies are described in <xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref><xref rid="bib32" ref-type="bibr"><sup>32</sup></xref><sup>,</sup><xref rid="bib33" ref-type="bibr"><sup>33</sup></xref><sup>,</sup><xref rid="bib37" ref-type="bibr">37</xref>, <xref rid="bib38" ref-type="bibr">38</xref>, <xref rid="bib39" ref-type="bibr">39</xref>, <xref rid="bib40" ref-type="bibr">40</xref>, <xref rid="bib41" ref-type="bibr">41</xref>, <xref rid="bib42" ref-type="bibr">42</xref>, <xref rid="bib43" ref-type="bibr">43</xref>, <xref rid="bib44" ref-type="bibr">44</xref>, <xref rid="bib45" ref-type="bibr">45</xref>, <xref rid="bib46" ref-type="bibr">46</xref>, <xref rid="bib47" ref-type="bibr">47</xref>, <xref rid="bib48" ref-type="bibr">48</xref>, <xref rid="bib49" ref-type="bibr">49</xref>; they consist of 10 case reports, 4 case series, and 1 retrospective cohort study. Excluded studies are summarized in <xref rid="appsec1" ref-type="sec">Supplemental Table&#x000a0;S2</xref>.<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Flowchart demonstrating the process of study selection according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for systematic reviews.<xref rid="bib35" ref-type="bibr"><sup>35</sup></xref> CDSR, Cochrane Database of Systematic Reviews; CENTRAL, Cochrane Central Register of Controlled Trials; MAC, mitral annular calcification.</p></caption><graphic xlink:href="gr2"/></fig><table-wrap position="float" id="tbl1"><label>Table&#x000a0;1</label><caption><p>Cases (n&#x000a0;= 22) of mitral annular calcification (MAC) thrombus</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Study; country</th><th>Age, y</th><th>Sex</th><th>Initial presentation</th><th>Thrombus location and size (mm)</th><th>Management</th><th>Outcome and follow-up</th></tr></thead><tbody><tr><td>Stein and Soble<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref> (1995); USA</td><td>74</td><td>F</td><td>Stroke</td><td>LA side, posterior annulus;<break/>2</td><td>Anticoagulation (warfarin)</td><td>Thrombus resolved, no recurrence</td></tr><tr><td>Stein and Soble<xref rid="bib33" ref-type="bibr"><sup>33</sup></xref> (1995); USA</td><td>47</td><td>F</td><td>Stroke</td><td>LA side, posterior leaflet;<break/>5</td><td>Anticoagulation (warfarin)</td><td>Thrombus resolved, no recurrence</td></tr><tr><td>Malaterre et&#x000a0;al.<xref rid="bib37" ref-type="bibr"><sup>37</sup></xref> (1996);<break/>France</td><td>83</td><td>F</td><td>Stroke</td><td>LV side, unknown attachment;<break/>18</td><td>Anticoagulation (UFH followed by warfarin)</td><td>Thrombus resolved, at follow-up free of new symptoms</td></tr><tr><td>Eicher et&#x000a0;al.<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> (1997) France</td><td>60</td><td>F</td><td>Stroke</td><td>LA and LV side, unknown attachment;<break/>27 x 10</td><td>Anticoagulation (UFH, followed by ASA&#x000a0;+ fluindione)</td><td>Thrombus resolved, no recurrence</td></tr><tr><td>Eicher et&#x000a0;al. <xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> (1997); France</td><td>73</td><td>F</td><td>TIA</td><td>LA and LV side, unknown attachment;<break/>13 x 8</td><td>Anticoagulation (UFH, followed by ASA&#x000a0;+ fluindione)</td><td>Thrombus resolved, no recurrence</td></tr><tr><td>Eicher et&#x000a0;al.<xref rid="bib38" ref-type="bibr"><sup>38</sup></xref> (1997);<break/>France</td><td>88</td><td>M</td><td>TIA</td><td>LA side, unknown attachment;<break/>18 x 8</td><td>Anticoagulation (UFH, followed by dipyridamole&#x000a0;+ fluindione)</td><td>Thrombus resolved, no recurrence</td></tr><tr><td>Shohat-Zabarski et&#x000a0;al.<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref> (2001);<break/>Israel</td><td>70</td><td>F</td><td>Stroke</td><td>LA side, unknown attachment;<break/>N/A</td><td>Initialanticoagulation, <break/>but eventually stopped due to bleeding (warfarin)</td><td>Initial reduction with anticoagulation, with stabilization thereafter, but recurrent emboli at 5 mo to eye after anticoagulation was stopped with persistent thrombus</td></tr><tr><td>Shohat-Zabarski et&#x000a0;al.<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref> (2001);<break/>Israel</td><td>69</td><td>F</td><td>Stroke</td><td>LA side, posterior leaflet;<break/>15</td><td>Anticoagulation (warfarin)</td><td>Thrombus resolved, no recurrence</td></tr><tr><td>Lahey and Horton<xref rid="bib40" ref-type="bibr"><sup>40</sup></xref> (2002);<break/>USA</td><td>22</td><td>F</td><td>MI</td><td>LA side, unknown attachment;<break/>N/A</td><td>Anticoagulation (warfarin)</td><td>Second stroke at 4 mo despite anticoagulation and found to have persistent MAC thrombus at that time</td></tr><tr><td>Kawano et&#x000a0;al.<xref rid="bib41" ref-type="bibr"><sup>41</sup></xref> (2005);<break/>Japan</td><td>50</td><td>M</td><td>Stroke</td><td>LA side, posterior leaflet;<break/>21 x 10</td><td>Anticoagulation (UFH, followed by mitral valvuloplasty)</td><td>Thrombus persisted with reduced size with anticoagulation, followed by surgical resection with mitral valvuloplasty; follow-up N/A</td></tr><tr><td>Choudry et&#x000a0;al.<xref rid="bib42" ref-type="bibr"><sup>42</sup></xref> (2009);<break/>United Kingdom</td><td>80</td><td>F</td><td>Presyncope</td><td>LV side, posterior leaflet;<break/>N/A</td><td>Anticoagulation (abciximab)</td><td>Coronary emboli in &#x0003c; 1 wk despite anticoagulation, followed by successful percutaneous retrieval of the coronary emboli; follow-up N/A</td></tr><tr><td>Konishi-Yakushiji et&#x000a0;al.<xref rid="bib43" ref-type="bibr"><sup>43</sup></xref> (2010);<break/>Japan</td><td>76</td><td>F</td><td>Stroke</td><td>LV side, unknown attachment;<break/>7 x 7</td><td>Anticoagulation (UFH, followed by ASA&#x000a0;+ clopidogrel&#x000a0;+ warfarin)</td><td>Second stroke despite anticoagulation, followed by enlargement of the mass; initiation of antiplatelet therapy with anticoagulation led to reduction of mass size (persisted at 12 mo) without any other embolic event</td></tr><tr><td>Sia et&#x000a0;al.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> (2010);<break/>Canada</td><td>73</td><td>F</td><td>Stroke</td><td>LV side, posterior annulus;<break/>48 x 5</td><td>Anticoagulation (UFH)</td><td>Plan for surgery but no thrombus seen on perioperative TEE; suspected resolution with heparin; follow-up N/A</td></tr><tr><td>Sia et&#x000a0;al.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> (2010);<break/>Canada</td><td>78</td><td>F</td><td>MI</td><td>LV side, unknown attachment;<break/>24 x 7</td><td>Anticoagulation (UFH, followed by W)</td><td>Thrombus resolved, no recurrence</td></tr><tr><td>Sia et&#x000a0;al.<xref rid="bib32" ref-type="bibr"><sup>32</sup></xref> (2010);<break/>Canada</td><td>62</td><td>M</td><td>MI</td><td>LV side, unknown attachment;<break/>15 x 11</td><td>Anticoagulation (UFH), followed by surgical resection</td><td>Successful resection; follow-up N/A</td></tr><tr><td>Nagai et&#x000a0;al.<xref rid="bib44" ref-type="bibr"><sup>44</sup></xref> (2012);<break/>Japan</td><td>80</td><td>F</td><td>Stroke</td><td>LV side, posterior leaflet;<break/>7 x 5</td><td>Anticoagulation (argatroban&#x000a0;+ ASA&#x000a0;+ cilostazol, followed by warfarin)</td><td>Initial reduction with anticoagulation, with persistent smaller thrombus at 8 mo, but no recurrent emboli</td></tr><tr><td>Mohan et&#x000a0;al.<xref rid="bib45" ref-type="bibr"><sup>45</sup></xref> (2016);<break/>India</td><td>73</td><td>M</td><td>Stroke</td><td>LV side, posterior leaflet;<break/>16 x 8</td><td>Anticoagulation (UFH&#x000a0;+ ASA&#x000a0;+ clopidrogel, followed by warfarin)</td><td>Thrombus resolved, no recurrence</td></tr><tr><td>Hadadi et&#x000a0;al.<xref rid="bib46" ref-type="bibr"><sup>46</sup></xref> (2016);<break/>USA</td><td>63</td><td>F</td><td>Incidental&#x02014; diabetic foot wound</td><td>LA side, posterior annulus;<break/>9 x 6</td><td>Anticoagulation (warfarin)</td><td>Thrombus resolved, no recurrence</td></tr><tr><td>Singu et&#x000a0;al.<xref rid="bib47" ref-type="bibr"><sup>47</sup></xref> (2017);<break/>Japan</td><td>89</td><td>F</td><td>Stroke</td><td>LA side, posterior annulus;<break/>18 x 10</td><td>Anticoagulation (warfarin)</td><td>Home warfarin for afib before and after stroke; second embolic event (stroke) 11 d after presentation, followed by complete resolution with anticoagulation; no recurrence</td></tr><tr><td>Suma et&#x000a0;al.<xref rid="bib48" ref-type="bibr"><sup>48</sup></xref> (2019);<break/>Italy</td><td>76</td><td>F</td><td>Stroke</td><td>LV side, posterior annulus;<break/>N/A</td><td>Surgical resection with MVR</td><td>Second stroke after presentation (unknown if patient on anticoagulation), followed by successful surgical resection; follow-up N/A</td></tr><tr><td>Chetrit et&#x000a0;al.<xref rid="bib49" ref-type="bibr"><sup>49</sup></xref> (2020);<break/>USA</td><td>77</td><td>F</td><td>CHF</td><td>LA side, posterior annulus;<break/>N/A</td><td>Surgical resection with MVR</td><td>Successful resection, follow-up N/A</td></tr><tr><td>Chetrit et&#x000a0;al.<xref rid="bib49" ref-type="bibr"><sup>49</sup></xref> (2020);<break/>USA</td><td>59</td><td>F</td><td>MI</td><td>LV side, AL;<break/>16 x 5</td><td>Surgical resection</td><td>Successful resection, follow up N/A</td></tr></tbody></table><table-wrap-foot><fn><p>Afib, atrial fibrillation; ASA, acetylsalicylic acid; F, female; LA, left atrium; LV, left ventricle; M, male; MI, myocardial infarction; MVR, mitral valve replacement; N/A, not available; TEE, transesophageal echocardiography; TIA, transient ischemic attack; UFH, unfractionated heparin.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec2.2"><title>Patient population</title><p id="p0060">Overall, 22 patients were identified. The median age at diagnosis was 73 years, with an interquartile range (IQR) of 62-78 years, and 82% (n&#x000a0;= 18) were female (see <xref rid="tbl2" ref-type="table">Table&#x000a0;2</xref>). Ethnicity frequently was not described, but the locations of publication spanned 7 countries. The most common comorbidities were hypertension, type 2 diabetes, chronic kidney disease, and coronary artery disease. No history of hypercoagulability was reported in any of the patients.<table-wrap position="float" id="tbl2"><label>Table&#x000a0;2</label><caption><p>Patient and thrombus characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Characteristics</th><th>All patients (n&#x000a0;= 22)</th></tr></thead><tbody><tr><td>Women</td><td align="char">18 (82)</td></tr><tr><td>Age, y</td><td>73 &#x000b1; 15.5</td></tr><tr><td>Hypertension</td><td align="char">8 (36)</td></tr><tr><td>Dyslipidemia</td><td align="char">1 (5)</td></tr><tr><td>Atrial fibrillation</td><td align="char">1 (5)</td></tr><tr><td>Type 2 diabetes</td><td align="char">6 (27)</td></tr><tr><td>Chronic kidney disease</td><td align="char">3 (14)</td></tr><tr><td>Dialysis</td><td align="char">2 (9)</td></tr><tr><td>Coronary artery disease</td><td align="char">3 (14)</td></tr><tr><td>Clinical presentation</td><td/></tr><tr><td>&#x000a0;Stroke; transient ischemic attack</td><td align="char">15 (68)</td></tr><tr><td>&#x000a0;Myocardial infarction</td><td align="char">4 (18)</td></tr><tr><td>&#x000a0;Other</td><td align="char">3 (14)</td></tr><tr><td>Thrombus size, mm (largest dimension)</td><td>16 &#x000b1; 90</td></tr><tr><td>Thrombus location (side)</td><td/></tr><tr><td>&#x000a0;Atrial</td><td align="char">10 (45)</td></tr><tr><td>&#x000a0;Ventricular</td><td align="char">10 (45)</td></tr><tr><td>&#x000a0;Both</td><td align="char">2 (9)</td></tr></tbody></table><table-wrap-foot><fn><p>Values are n (%), or median &#x000b1; interquartile range.</p></fn></table-wrap-foot></table-wrap></p><p id="p0065">The most common presentation was a cerebral vascular event, which occurred in 68% of patients (n&#x000a0;= 15), with most experiencing a stroke (n&#x000a0;= 13), and those remaining experiencing a transient ischemic attack (n&#x000a0;= 2). The second most common clinical presentation in 18% (n&#x000a0;= 4) was myocardial infarction. In 14% (n&#x000a0;= 3), thrombus on MAC was identified during investigations for other presentations, such as heart failure, presyncope, or diabetic foot wound.</p></sec><sec id="sec2.3"><title>Diagnosis and imaging characteristics</title><p id="p0070">All patients were diagnosed using either transthoracic echocardiography (TTE; n&#x000a0;= 18; 82%) or TEE(n&#x000a0;= 4; 18%). The MAC severity level was reported in 14 of 22 patients, as being severe in 11 (79%), moderate in 2 (14%), and mild in 1 (7%).</p><p id="p0075">Thrombus size was reported in 17 patients (77%), and the median widest dimension was 1.6 cm, with an IQR of 0.9-1.8 cm. Thrombus was identified on the atrial side of the mitral annulus in 10 patients (46%), on the ventricular side of the mitral valve in 10 patients (46%), and on both the atrial and ventricular sides in 2 patients (8%). The circumferential location of thrombus attachment was reported in 14 patients (64%), with the most-common attachment site located posteriorly in 12 patients (55%). Only 2 cases (10%) reported anterior thrombus attachment.</p></sec><sec id="sec2.4"><title>Management</title><p id="p0080">The main modalities for treatment of MAC thrombus were anticoagulation therapy and surgery. A flowchart demonstrating anticoagulation and surgical management for the patients is presented in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>. Seventeen of the patients (77%) were treated only medically, with anticoagulation therapy with the potential addition of antiplatelet agents (<xref rid="fig3" ref-type="fig">Fig.&#x000a0;3</xref>). Agents used included heparin, vitamin-K antagonists (warfarin, fluindione), anti-glycoprotein IIb/IIa receptor antibody (abciximab), direct thrombin inhibitor (argatroban), dipyridamole, aspirin, and clopidogrel. Some of these agents were provided simultaneously, and some consecutively, in the same patient. Fourteen patients (64%) received a vitamin-K antagonist at some point during their therapy, and 10 (45%) received heparin. Most anticoagulated patients received warfarin alone, with a target international normalized ratio (INR) of between 2 and 3. In 6 cases, antiplatelet therapy was added to anticoagulation therapy (aspirin alone, dipyridamole alone, aspirin&#x000a0;+ cilostazol, or aspirin&#x000a0;+ clopidogrel). These combinations were sometimes used upfront (in 4 cases), and occasionally (in 2 cases), they were used due to inadequate response to anticoagulation therapy alone. The add-on strategy was effective when required. In 1 case, a higher INR target (&#x0003e; 3.0) was used, due to an inadequate response to an INR of between 2 and 3. The duration of anticoagulation therapy was unclear for half of the cases (n&#x000a0;= 11), and for the remainder, treatment duration ranged from 1 week to lifelong.<fig id="fig3"><label>Figure&#x000a0;3</label><caption><p>Flowchart demonstrating outcomes for patients with mitral annular calcification thrombus, managed by either anticoagulation therapy alone or surgery.</p></caption><graphic xlink:href="gr3"/></fig></p><p id="p0085">Five patients (23%) underwent cardiac surgery (<xref rid="tbl3" ref-type="table">Table&#x000a0;3</xref>). Two of these 5 patients had received successful anticoagulation therapy. Whether anticoagulation therapy was received prior to surgery was unknown for the remaining 3 patients. The most common indication for surgery was prevention of recurrent embolization, which occurred in 3 patients (14%). The exact reasons for surgery in these 3 patients were as follows: (i) incomplete resolution after 1 month of anticoagulation therapy; (ii) recurrent ischemic stroke during the admission; and (iii) an initial diagnosis of fibroelastoma that intraoperatively was found to be thrombus. Of these 3 cases, only 1 patient received anticoagulation therapy prior to surgery (for 1 month, with incomplete resolution of the thrombus). For the other 2 patients, whether anticoagulation therapy was started before the surgery is unclear. The remaining 2 patients (9%) underwent surgery for other indications. such as severe mitral stenosis or severe coronary artery disease, during which the thrombus was removed. Three patients benefited from mitral surgery at the time of thrombus resection (1 valvuloplasty and 2 replacements). The indication clearly was due to severe mitral stenosis for only 1 of these 3 patients. The valve and annulus were calcified for the other 2 patients, but no hemodynamically significant stenosis was described in the reports.<table-wrap position="float" id="tbl3"><label>Table&#x000a0;3</label><caption><p>Indications for surgery</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Indication</th><th>n (%)</th></tr></thead><tbody><tr><td>Prevention of additional embolic events</td><td align="char">3 (14)</td></tr><tr><td>Symptomatic mitral stenosis</td><td align="char">1 (5)</td></tr><tr><td>Other surgical indication&#x02014;coronary artery disease</td><td align="char">1 (5)</td></tr></tbody></table><table-wrap-foot><fn><p>% is % of total patients.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec2.5"><title>Outcomes</title><p id="p0090">Outcomes are presented in <xref rid="fig3" ref-type="fig">Figure&#x000a0;3</xref>. After their initial clinical presentation, thromboembolic events occurred in 6 patients (27%), including 3 patients who had received successful anticoagulation therapy. The most common thromboembolic event was stroke (n&#x000a0;= 4; 18%), followed in frequency by coronary embolism (n&#x000a0;= 1; 5%), and an embolic event to the eye (n&#x000a0;= 1; 5%). The timeline for these events ranged from &#x0003c;1 week to &#x02264; 5 months from the initial presentation. No in-hospital mortality was reported.</p><p id="p0095">Follow-up care was provided in 16 patients (73%). The median follow-up period was 3 months (IQR: 1-9), with a range from 10 days to 14 months. For those treated with anticoagulation therapy, 23% (n&#x000a0;= 5) had persistent thrombus with or without embolization identified on imaging during follow-up care, ranging from 2 weeks to 12 months, with a median of 3 months. One of these patients subsequently underwent surgery. One patient had a recurrent embolic event. All patients treated with surgery had resolution of MAC thrombus. No patient mortality was reported during the follow-up period.</p></sec><sec id="sec2.6"><title>Quality evaluation</title><p id="p0100">The overall methodological quality level of the case reports included in our systematic review was reasonable, with a low to moderate risk of bias (see <xref rid="appsec1" ref-type="sec">Supplemental Table&#x000a0;S1</xref>). Most cases provided a satisfactory description of the presence of MAC, thrombus attached to MAC, patients&#x02019; past medical history, laboratory and imaging tests, management, and outcomes. However, whether most of these case reports represent the authors&#x02019; whole experience is unclear. Adequate disease and outcome ascertainment, with consistent investigations, was present in all cases. Follow-up care was described adequately in only half of the case reports (53%), and investigations to identify alternative causes that might explain the observation were reported in only two-thirds of the cases (67%).</p></sec></sec><sec id="sec3"><title>Discussion</title><p id="p0105">Thrombus formation on MAC is a known complication that is associated with thromboembolic events. This systematic review is the first to examine the management and outcomes of MAC thrombus. The 4 main findings (see the graphical abstract) are as follows: (i) the most common clinical presentation for MAC thrombus was a cerebrovascular event; (ii) thromboembolic events after initial presentation were frequent, occurring in 27% of patients (n&#x000a0;= 6); (iii) although most patients were managed with anticoagulation therapy alone, a significant number (3 of 22 patients; 14%) required cardiac surgery for recurrent embolization; and (iv) despite anticoagulation therapy, persistent thrombus was observed in 23% of patients (n&#x000a0;= 5), at a median follow-up duration of 3 months.</p><p id="p0110">In this systematic review of MAC thrombus, the most common clinical presentation was a cerebrovascular event. MAC itself is known to be a risk factor for ischemic stroke,<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="bib21" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="bib50" ref-type="bibr"><sup>50</sup></xref> with a relative risk of 2.1 reported in the Framingham Heart Study, and a multivariable-adjusted hazard ratio of 1.89 reported in the Strong Heart Study.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="bib21" ref-type="bibr"><sup>21</sup></xref><sup>,</sup><xref rid="bib22" ref-type="bibr"><sup>22</sup></xref><sup>,</sup><xref rid="bib51" ref-type="bibr">51</xref>, <xref rid="bib52" ref-type="bibr">52</xref>, <xref rid="bib53" ref-type="bibr">53</xref> Multiple mechanisms have been proposed for the association between MAC and ischemic stroke, such as concurrent atrial fibrillation, atherosclerosis, and calcific emboli.<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref><sup>,</sup><xref rid="bib24" ref-type="bibr"><sup>24</sup></xref><sup>,</sup><xref rid="bib39" ref-type="bibr"><sup>39</sup></xref><sup>,</sup><xref rid="bib54" ref-type="bibr"><sup>54</sup></xref><sup>,</sup><xref rid="bib55" ref-type="bibr"><sup>55</sup></xref> For instance, MAC may be associated with a degenerative process affecting mitral leaflet mobility, which could in turn influence thrombus formation, particularly if significant mitral stenosis and left atrial structural and functional abnormalities are present. Thrombus formation on MAC also could be a significant mechanism for MAC&#x02019;s association with stroke,<xref rid="bib39" ref-type="bibr"><sup>39</sup></xref><sup>,</sup><xref rid="bib55" ref-type="bibr"><sup>55</sup></xref> and it should be considered in ischemic stroke patients who are found to have MAC, on TTE. In this systematic review, some cases of MAC thrombus were identified only with TEE. Therefore, although TTE is a mainstay of the workup for etiology of ischemic stroke, routine TEE in stroke patients with significant MAC may be indicated, especially in the presence of recurrent events. Thrombus on MAC, particularly on the left atrial side, may be missed on TTE, due to shadowing from the MAC.</p><p id="p0115">We found that patients with MAC thrombus are at risk for thromboembolic events after diagnosis while they are undergoing anticoagulation therapy. However, the treatment strategies were broad, both in terms of regimens (antiplatelet agents and anticoagulation) and duration (ranging from 1 week to lifelong), which may have affected the outcomes. While it is unknown whether patients were within therapeutic range at the time of these events, MAC thrombus may be associated with a persistently elevated thromboembolic risk, both in the short- and mid-term, despite anticoagulation therapy. Furthermore, during follow-up care, persistent thrombus, despite anticoagulation therapy, was found in several patients, and it may be the mechanism for these recurrent embolic events. Thus, MAC thrombus should be considered a high-risk presentation that is associated with a significant incidence of morbidity. Early identification, appropriate management, close monitoring, and follow-up care are key to managing this risk of recurrent embolic events. Repeated imaging to ensure thrombus resolution may be prudent.</p><p id="p0120">Most patients in our review were managed with anticoagulation therapy alone, although a wide variety of anticoagulant regimens were utilized. This situation may have contributed to both the rates of persistent thrombus observed and the number of embolic events that occurred after diagnosis. The ideal anticoagulation therapy regimen and duration remain unclear. Furthermore, delineating the role for use of preventative anticoagulant or antiplatelet therapy for MAC thrombus, particularly in patients with MAC and atrial fibrillation, or with severe MAC, would be beneficial. The ideal timing for a follow-up echocardiogram after initiating anticoagulation therapy also remains to be determined. In most cases, an echocardiogram performed after 4-8 weeks of anticoagulation therapy showed that a partial or complete reduction in thrombus size had occurred. However, some reports demonstrated a reduction in thrombus size within a few days. Given this variability, repeating the echocardiogram 4-8 weeks after achieving therapeutic anticoagulation is reasonable.</p><p id="p0125">Although most patients were managed with anticoagulation therapy alone, a significant number required surgery to prevent recurrent embolization. The indications for surgical management of MAC thrombus without recurrent embolization remain to be elucidated. Surgical treatment of MAC itself is indicated when it results in severe mitral valve stenosis or regurgitation.<xref rid="bib56" ref-type="bibr"><sup>56</sup></xref><sup>,</sup><xref rid="bib57" ref-type="bibr"><sup>57</sup></xref> However, significant challenges arise with the surgical management of MAC, and by extension, MAC thrombus. Patients who have MAC tend to be of an advanced age and to have significant cardiac and extracardiac comorbidities that may exclude them from surgical candidacy.<xref rid="bib57" ref-type="bibr"><sup>57</sup></xref><sup>,</sup><xref rid="bib58" ref-type="bibr"><sup>58</sup></xref> Also, multiple anatomic constraints can make surgical MAC management difficult, including the risk of annular disruption, atrioventricular dissociation, and paravalvular regurgitation.<xref rid="bib58" ref-type="bibr"><sup>58</sup></xref> Transcatheter mitral valve replacement in MAC has been associated with a high incidence of morbidity and mortality and would not address the thrombus.<xref rid="bib58" ref-type="bibr"><sup>58</sup></xref> For optimal management, a dedicated multidisciplinary team for MAC surgical management should be involved to determine potential valve solutions.<xref rid="bib57" ref-type="bibr"><sup>57</sup></xref> The indications for surgery for prevention of recurrent embolization of MAC thrombus, however, remain unclear.</p><sec id="sec3.1"><title>Limitations</title><p id="p0130">Our study, although it provides valuable insights, has several limitations. The systematic literature search identified only 22 patients, despite use of broad search criteria. This small sample size may not represent the management and outcomes of MAC thrombus accurately, due to publication bias and the fact that some data were unavailable or were not reported systematically. Moreover, in some cases, whether competing comorbidities contributed to cerebrovascular events rather than a cardioembolic event is unclear. Confirmation of the diagnosis of MAC thrombus can be challenging. As we included only those cases with appropriate pathology, characteristic imaging, or response to therapeutic anticoagulation, MAC thrombus cases that did not meet these criteria may have been excluded. However, our cases inadvertently could have included those with mobile degenerative debris from MAC or caseous calcification. Additionally, asymptomatic MAC thrombus may not be recognized or described in publications, thereby altering our understanding of the clinical presentation and outcomes of MAC thrombus. Furthermore, the indications for surgery were limited to only 5 patients, a number too small to establish definitive indications for surgery. Finally, the median follow-up period was only 3 months, and adequate follow-up care was reported in only 53% of the case reports. This short duration and inadequacy of long-term surveillance limit our ability to determine the impact of an intervention on patients with MAC, who typically have multiple comorbidities.</p></sec><sec id="sec3.2"><title>Conclusion</title><p id="p0135">This systematic review is the first to examine the management and outcomes of patients with MAC thrombus. In patients with MAC who present with a thromboembolic event, careful echocardiographic interrogation of MAC to exclude the presence of a thrombus should be performed. The diagnosis of thrombus can be challenging, as the differential can include mobile degenerative debris from MAC or caseous calcification. Diagnosis requires either pathology, supportive imaging, or resolution with treatment. Although thrombus often resolves with anticoagulation therapy, persistent thrombus, despite anticoagulation therapy, and recurrent embolization was observed in this population and may be due to the MAC microenvironment. Although most patients potentially can be managed with anticoagulation therapy alone, some patients may require surgery for recurrent embolization. However, these patients often are highly comorbid, which may complicate the diagnosis and management of those challenging cases. The paucity of studies identified in this systematic review limits our ability to identify a clear management strategy for this potentially underreported pathology. Larger studies on MAC thrombus management are needed to elucidate what constitutes the optimal long-term care for these patients.</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Kanjanauthai</surname><given-names>S.</given-names></name><name><surname>Nasir</surname><given-names>K.</given-names></name><name><surname>Katz</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Relationships of mitral annular calcification to cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA)</article-title><source>Atherosclerosis</source><volume>213</volume><year>2010</year><fpage>558</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">20926076</pub-id>
</element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Abramowitz</surname><given-names>Y.</given-names></name><name><surname>Jilaihawi</surname><given-names>H.</given-names></name><name><surname>Chakravarty</surname><given-names>T.</given-names></name><name><surname>Mack</surname><given-names>M.J.</given-names></name><name><surname>Makkar</surname><given-names>R.R.</given-names></name></person-group><article-title>Mitral annulus calcification</article-title><source>J&#x000a0;Am Coll Cardiol</source><volume>66</volume><year>2015</year><fpage>1934</fpage><lpage>1941</lpage><pub-id pub-id-type="pmid">26493666</pub-id>
</element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sref3"><person-group person-group-type="author"><name><surname>Birudaraju</surname><given-names>D.</given-names></name><name><surname>Cherukuri</surname><given-names>L.</given-names></name><name><surname>Pranesh</surname><given-names>S.</given-names></name><name><surname>Budoff</surname><given-names>M.J.</given-names></name></person-group><article-title>Current methods to assess mitral annular calcification and its risk factors</article-title><source>Expert Rev Cardiovasc Ther</source><volume>19</volume><year>2021</year><fpage>787</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">34348555</pub-id>
</element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>R.A.</given-names></name><name><surname>Vahanian</surname><given-names>A.</given-names></name><name><surname>Eleid</surname><given-names>M.F.</given-names></name><name><surname>Mack</surname><given-names>M.J.</given-names></name></person-group><article-title>Mitral valve disease&#x02014;current management and future challenges</article-title><source>Lancet</source><volume>387</volume><year>2016</year><fpage>1324</fpage><lpage>1334</lpage><pub-id pub-id-type="pmid">27025438</pub-id>
</element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="journal" id="sref5"><person-group person-group-type="author"><name><surname>Massera</surname><given-names>D.</given-names></name><name><surname>Kizer</surname><given-names>J.R.</given-names></name><name><surname>Dweck</surname><given-names>M.R.</given-names></name></person-group><article-title>Mechanisms of mitral annular calcification</article-title><source>Trends Cardiovasc Med</source><volume>30</volume><year>2020</year><fpage>289</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">31402089</pub-id>
</element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="journal" id="sref6"><person-group person-group-type="author"><name><surname>Massera</surname><given-names>D.</given-names></name><name><surname>Trivieri</surname><given-names>M.G.</given-names></name><name><surname>Andrews</surname><given-names>J.P.M.</given-names></name><etal/></person-group><article-title>Disease activity in mitral annular calcification</article-title><source>Circ Cardiovasc Imaging</source><volume>12</volume><year>2019</year><object-id pub-id-type="publisher-id">e008513</object-id></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>E.</given-names></name><name><surname>Harkins</surname><given-names>D.</given-names></name><name><surname>Taylor</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Epidemiology of mitral annular calcification and its predictive value for coronary events in African Americans: the Jackson Cohort of the Atherosclerotic Risk in Communities Study</article-title><source>Am Heart J</source><volume>148</volume><year>2004</year><fpage>979</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">15632881</pub-id>
</element-citation></ref><ref id="bib8"><label>8</label><element-citation publication-type="journal" id="sref8"><person-group person-group-type="author"><name><surname>Benjamin</surname><given-names>E.J.</given-names></name><name><surname>Plehn</surname><given-names>J.F.</given-names></name><name><surname>D'Agostino</surname><given-names>R.B.</given-names></name><etal/></person-group><article-title>Mitral annular calcification and the risk of stroke in an elderly cohort</article-title><source>N&#x000a0;Engl J Med</source><volume>327</volume><year>1992</year><fpage>374</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">1625711</pub-id>
</element-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Waller</surname><given-names>B.F.</given-names></name><name><surname>Roberts</surname><given-names>W.C.</given-names></name></person-group><article-title>Cardiovascular disease in the very elderly. Analysis of 40 necropsy patients aged 90 years or over</article-title><source>Am J Cardiol</source><volume>51</volume><year>1983</year><fpage>403</fpage><lpage>421</lpage><pub-id pub-id-type="pmid">6823855</pub-id>
</element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Okura</surname><given-names>H.</given-names></name><name><surname>Nakada</surname><given-names>Y.</given-names></name><name><surname>Nogi</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Prevalence of mitral annular calcification and its association with mitral valvular disease</article-title><source>Echocardiography</source><volume>38</volume><year>2021</year><fpage>1907</fpage><lpage>1912</lpage><pub-id pub-id-type="pmid">34719060</pub-id>
</element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Lazaros</surname><given-names>G.</given-names></name><name><surname>Toutouzas</surname><given-names>K.</given-names></name><name><surname>Drakopoulou</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Aortic sclerosis and mitral annulus calcification: a window to vascular atherosclerosis?</article-title><source>Expert Rev Cardiovasc Ther</source><volume>11</volume><year>2013</year><fpage>863</fpage><lpage>877</lpage><pub-id pub-id-type="pmid">23895030</pub-id>
</element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>C.S.</given-names></name><name><surname>Vasan</surname><given-names>R.S.</given-names></name><name><surname>Parise</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study</article-title><source>Circulation</source><volume>107</volume><year>2003</year><fpage>1492</fpage><lpage>1496</lpage><pub-id pub-id-type="pmid">12654605</pub-id>
</element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>Q.</given-names></name></person-group><article-title>Mitral annular calcification is associated with atrial fibrillation and major cardiac adverse events in atrial fibrillation patients: a systematic review and meta-analysis</article-title><source>Medicine (Baltimore)</source><volume>98</volume><year>2019</year><object-id pub-id-type="publisher-id">e17548</object-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>Toufan</surname><given-names>M.</given-names></name><name><surname>Javadrashid</surname><given-names>R.</given-names></name><name><surname>Paak</surname><given-names>N.</given-names></name><name><surname>Gojazadeh</surname><given-names>M.</given-names></name><name><surname>Khalili</surname><given-names>M.</given-names></name></person-group><article-title>Relationship between incidentally detected calcification of the mitral valve on 64-row multidetector computed tomography and mitral valve disease on echocardiography</article-title><source>Int J Gen Med</source><volume>5</volume><year>2012</year><fpage>839</fpage><lpage>843</lpage><pub-id pub-id-type="pmid">23077412</pub-id>
</element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Ozawa</surname><given-names>T.</given-names></name><name><surname>Kawakami</surname><given-names>S.</given-names></name><name><surname>Matsumoto</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Infective endocarditis involving mitral annular calcification leading to abscess formation rupture into pericardium</article-title><source>Circ J</source><volume>83</volume><year>2019</year><fpage>1415</fpage><pub-id pub-id-type="pmid">30369563</pub-id>
</element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>C.S.</given-names></name><name><surname>Parise</surname><given-names>H.</given-names></name><name><surname>Vasan</surname><given-names>R.S.</given-names></name><etal/></person-group><article-title>Mitral annular calcification is a predictor for incident atrial fibrillation</article-title><source>Atherosclerosis</source><volume>173</volume><year>2004</year><fpage>291</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">15064104</pub-id>
</element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Jozsa</surname><given-names>C.</given-names></name><name><surname>Budwal</surname><given-names>B.</given-names></name><name><surname>Lloyd</surname><given-names>G.</given-names></name><name><surname>Bhattacharyya</surname><given-names>S.</given-names></name></person-group><article-title>Association between mitral annular calcification and progression of mitral and aortic stenoses</article-title><source>Echocardiography</source><volume>37</volume><year>2020</year><fpage>1543</fpage><lpage>1550</lpage><pub-id pub-id-type="pmid">32909655</pub-id>
</element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Barasch</surname><given-names>E.</given-names></name><name><surname>Gottdiener</surname><given-names>J.S.</given-names></name><name><surname>Marino Larsen</surname><given-names>E.K.</given-names></name><name><surname>Chaves</surname><given-names>P.H.</given-names></name><name><surname>Newman</surname><given-names>A.B.</given-names></name></person-group><article-title>Cardiovascular morbidity and mortality in community-dwelling elderly individuals with calcification of the fibrous skeleton of the base of the heart and aortosclerosis (The Cardiovascular Health Study)</article-title><source>Am J Cardiol</source><volume>97</volume><year>2006</year><fpage>1281</fpage><lpage>1286</lpage><pub-id pub-id-type="pmid">16635596</pub-id>
</element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Adler</surname><given-names>Y.</given-names></name><name><surname>Koren</surname><given-names>A.</given-names></name><name><surname>Fink</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Association between mitral annulus calcification and carotid atherosclerotic disease</article-title><source>Stroke</source><volume>29</volume><year>1998</year><fpage>1833</fpage><lpage>1837</lpage><pub-id pub-id-type="pmid">9731604</pub-id>
</element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Shim</surname><given-names>C.Y.</given-names></name><name><surname>Hong</surname><given-names>G.R.</given-names></name><name><surname>Jeong</surname><given-names>H.</given-names></name><name><surname>Ha</surname><given-names>J.W.</given-names></name></person-group><article-title>Morphological and functional characteristics of mitral annular calcification and their relationship to stroke</article-title><source>PLoS One</source><volume>15</volume><year>2020</year><object-id pub-id-type="publisher-id">e0227753</object-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="journal" id="sref21"><person-group person-group-type="author"><name><surname>Kizer</surname><given-names>J.R.</given-names></name><name><surname>Wiebers</surname><given-names>D.O.</given-names></name><name><surname>Whisnant</surname><given-names>J.P.</given-names></name><etal/></person-group><article-title>Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: the Strong Heart Study</article-title><source>Stroke</source><volume>36</volume><year>2005</year><fpage>2533</fpage><lpage>2537</lpage><pub-id pub-id-type="pmid">16254219</pub-id>
</element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>De Marco</surname><given-names>M.</given-names></name><name><surname>Gerdts</surname><given-names>E.</given-names></name><name><surname>Casalnuovo</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study</article-title><source>Am J Hypertens</source><volume>26</volume><year>2013</year><fpage>567</fpage><lpage>573</lpage><pub-id pub-id-type="pmid">23391619</pub-id>
</element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>O'Neal</surname><given-names>W.T.</given-names></name><name><surname>Efird</surname><given-names>J.T.</given-names></name><name><surname>Nazarian</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Mitral annular calcification progression and the risk of atrial fibrillation: results from MESA</article-title><source>Eur Heart J Cardiovasc Imaging</source><volume>19</volume><year>2018</year><fpage>279</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">28460029</pub-id>
</element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Adler</surname><given-names>Y.</given-names></name><name><surname>Fink</surname><given-names>N.</given-names></name><name><surname>Spector</surname><given-names>D.</given-names></name><name><surname>Wiser</surname><given-names>I.</given-names></name><name><surname>Sagie</surname><given-names>A.</given-names></name></person-group><article-title>Mitral annulus calcification&#x02014;a window to diffuse atherosclerosis of the vascular system</article-title><source>Atherosclerosis</source><volume>155</volume><year>2001</year><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11223420</pub-id>
</element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Chaudhry</surname><given-names>F.S.</given-names></name><name><surname>Vela-Duarte</surname><given-names>D.</given-names></name><name><surname>Biller</surname><given-names>J.</given-names></name></person-group><article-title>Stroke due to calcific embolism after cardiac procedures</article-title><source>Arq Neuropsiquiatr</source><volume>71</volume><year>2013</year><fpage>416</fpage><pub-id pub-id-type="pmid">23828539</pub-id>
</element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Karan</surname><given-names>A.</given-names></name><name><surname>Feghaly</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>H.J.</given-names></name><name><surname>Akinjogbin</surname><given-names>T.O.</given-names></name><name><surname>Sattiraju</surname><given-names>S.</given-names></name></person-group><article-title>A&#x000a0;case of multiple calcific embolic strokes in a patient with a porcelain left atrium</article-title><source>Cureus</source><volume>13</volume><year>2021</year><object-id pub-id-type="publisher-id">e18585</object-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Mouton</surname><given-names>P.</given-names></name><name><surname>Biousse</surname><given-names>V.</given-names></name><name><surname>Crassard</surname><given-names>I.</given-names></name><name><surname>Bousson</surname><given-names>V.</given-names></name><name><surname>Bousser</surname><given-names>M.G.</given-names></name></person-group><article-title>Ischemic stroke due to calcific emboli from mitral valve annulus calcification</article-title><source>Stroke</source><volume>28</volume><year>1997</year><fpage>2325</fpage><lpage>2326</lpage><pub-id pub-id-type="pmid">9368587</pub-id>
</element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Motwani</surname><given-names>M.</given-names></name><name><surname>Fairbairn</surname><given-names>T.A.</given-names></name><name><surname>Jogiya</surname><given-names>R.</given-names></name><name><surname>Greenwood</surname><given-names>J.P.</given-names></name><name><surname>Plein</surname><given-names>S.</given-names></name></person-group><article-title>Caseous calcification of the mitral valve complicated by embolization, mitral regurgitation, and pericardial constriction</article-title><source>Eur Heart J Cardiovasc Imaging</source><volume>13</volume><year>2012</year><fpage>792</fpage><pub-id pub-id-type="pmid">22875831</pub-id>
</element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Matsou</surname><given-names>A.</given-names></name><name><surname>Symeonidis</surname><given-names>C.</given-names></name><name><surname>Dermenoudi</surname><given-names>M.</given-names></name><name><surname>Sachpekidis</surname><given-names>V.</given-names></name></person-group><article-title>Caseous calcification of the mitral valve annulus: a rare cause of bilateral cerebral and ocular embolisation</article-title><source>BMJ Case Rep</source><volume>2018</volume><year>2018</year><object-id pub-id-type="publisher-id">bcr2018224322</object-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Higashi</surname><given-names>H.</given-names></name><name><surname>Ohara</surname><given-names>T.</given-names></name><name><surname>Nakatani</surname><given-names>S.</given-names></name><etal/></person-group><article-title>A&#x000a0;case of caseous calcification of the mitral annulus: a potential source of embolic stroke</article-title><source>J&#x000a0;Cardiol Cases</source><volume>2</volume><year>2010</year><fpage>e141</fpage><lpage>e143</lpage><pub-id pub-id-type="pmid">30532814</pub-id>
</element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Faggiano</surname><given-names>P.</given-names></name><name><surname>Dasseni</surname><given-names>N.</given-names></name><name><surname>Gaibazzi</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Cardiac calcification as a marker of subclinical atherosclerosis and predictor of cardiovascular events: a review of the evidence</article-title><source>Eur J Prev Cardiol</source><volume>26</volume><year>2019</year><fpage>1191</fpage><lpage>1204</lpage><pub-id pub-id-type="pmid">30845832</pub-id>
</element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Sia</surname><given-names>Y.T.</given-names></name><name><surname>Dulay</surname><given-names>D.</given-names></name><name><surname>Burwash</surname><given-names>I.G.</given-names></name><etal/></person-group><article-title>Mobile ventricular thrombus arising from the mitral annulus in patients with dense mitral annular calcification</article-title><source>Eur J Echocardiogr</source><volume>11</volume><year>2010</year><fpage>198</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">19919957</pub-id>
</element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Stein</surname><given-names>J.H.</given-names></name><name><surname>Soble</surname><given-names>J.S.</given-names></name></person-group><article-title>Thrombus associated with mitral valve calcification. A possible mechanism for embolic stroke</article-title><source>Stroke</source><volume>26</volume><year>1995</year><fpage>1697</fpage><lpage>1699</lpage><pub-id pub-id-type="pmid">7660417</pub-id>
</element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="other" id="sref34"><person-group person-group-type="author"><name><surname>Cintosun</surname><given-names>A.</given-names></name><name><surname>Orchanian-Cheff</surname><given-names>A.</given-names></name><name><surname>Tsang</surname><given-names>W.</given-names></name></person-group><article-title>Thrombus on mitral annular calcification: a systematic review of natural history and outcomes</article-title><comment>Available at:</comment><ext-link ext-link-type="uri" xlink:href="https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022299281" id="intref0025145896">https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022299281</ext-link></element-citation></ref><ref id="bib35"><label>35</label><element-citation publication-type="journal" id="sref35"><person-group person-group-type="author"><name><surname>Page</surname><given-names>M.J.</given-names></name><name><surname>McKenzie</surname><given-names>J.E.</given-names></name><name><surname>Bossuyt</surname><given-names>P.M.</given-names></name><etal/></person-group><article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title><source>Rev Esp Cardiol (Engl Ed)</source><volume>74</volume><year>2021</year><fpage>790</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">34446261</pub-id>
</element-citation></ref><ref id="bib36"><label>36</label><element-citation publication-type="journal" id="sref36"><person-group person-group-type="author"><name><surname>Murad</surname><given-names>M.H.</given-names></name><name><surname>Sultan</surname><given-names>S.</given-names></name><name><surname>Haffar</surname><given-names>S.</given-names></name><name><surname>Bazerbachi</surname><given-names>F.</given-names></name></person-group><article-title>Methodological quality and synthesis of case series and case reports</article-title><source>BMJ Evid Based Med</source><volume>23</volume><year>2018</year><fpage>60</fpage><lpage>63</lpage></element-citation></ref><ref id="bib37"><label>37</label><element-citation publication-type="journal" id="sref37"><person-group person-group-type="author"><name><surname>Malaterre</surname><given-names>H.R.</given-names></name><name><surname>Habib</surname><given-names>G.</given-names></name><name><surname>Leude</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Embolic thrombus on mitral anulus calcification</article-title><source>J&#x000a0;Am Soc Echocardiogr</source><volume>9</volume><year>1996</year><fpage>894</fpage><lpage>896</lpage><pub-id pub-id-type="pmid">8943455</pub-id>
</element-citation></ref><ref id="bib38"><label>38</label><element-citation publication-type="journal" id="sref38"><person-group person-group-type="author"><name><surname>Eicher</surname><given-names>J.C.</given-names></name><name><surname>Soto</surname><given-names>F.X.</given-names></name><name><surname>DeNadai</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Possible association of thrombotic, nonbacterial vegetations of the mitral ring-mitral annular calcium and stroke</article-title><source>Am J Cardiol</source><volume>79</volume><year>1997</year><fpage>1712</fpage><lpage>1715</lpage><pub-id pub-id-type="pmid">9202375</pub-id>
</element-citation></ref><ref id="bib39"><label>39</label><element-citation publication-type="journal" id="sref39"><person-group person-group-type="author"><name><surname>Shohat-Zabarski</surname><given-names>R.</given-names></name><name><surname>Paz</surname><given-names>R.</given-names></name><name><surname>Adler</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Mitral annulus calcification with a mobile component as a possible source of embolism</article-title><source>Am J Geriatr Cardiol</source><volume>10</volume><year>2001</year><fpage>196</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">11455239</pub-id>
</element-citation></ref><ref id="bib40"><label>40</label><element-citation publication-type="journal" id="sref40"><person-group person-group-type="author"><name><surname>Lahey</surname><given-names>T.</given-names></name><name><surname>Horton</surname><given-names>S.</given-names></name></person-group><article-title>Massive left atrial calcification and devastating systemic emboli in a patient with chronic renal failure</article-title><source>Am J Kidney Dis</source><volume>40</volume><year>2002</year><fpage>416</fpage><lpage>419</lpage><pub-id pub-id-type="pmid">12148118</pub-id>
</element-citation></ref><ref id="bib41"><label>41</label><element-citation publication-type="journal" id="sref41"><person-group person-group-type="author"><name><surname>Kawano</surname><given-names>H.</given-names></name><name><surname>Terasaki</surname><given-names>T.</given-names></name><name><surname>Hashimoto</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Cardioembolic stroke due to mitral annular calcification with a mobile component</article-title><source>Clin Neurol</source><volume>45</volume><year>2005</year><fpage>383</fpage><lpage>385</lpage><comment>[in Japanese]</comment></element-citation></ref><ref id="bib42"><label>42</label><element-citation publication-type="journal" id="sref42"><person-group person-group-type="author"><name><surname>Choudry</surname><given-names>F.A.</given-names></name><name><surname>Opel</surname><given-names>A.</given-names></name><name><surname>Coghlan</surname><given-names>J.G.</given-names></name></person-group><article-title>Coronary artery embolism from native mitral valve thrombus</article-title><source>Eur Heart J</source><volume>30</volume><year>2009</year><fpage>1321</fpage><pub-id pub-id-type="pmid">19299429</pub-id>
</element-citation></ref><ref id="bib43"><label>43</label><element-citation publication-type="journal" id="sref43"><person-group person-group-type="author"><name><surname>Konishi-Yakushiji</surname><given-names>M.</given-names></name><name><surname>Yakushiji</surname><given-names>Y.</given-names></name><name><surname>Kotooka</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Sonographic confirmation of the association between calcified cerebral emboli and mitral annular calcification</article-title><source>J&#x000a0;Ultrasound Med</source><volume>29</volume><year>2010</year><fpage>1507</fpage><lpage>1510</lpage><pub-id pub-id-type="pmid">20876908</pub-id>
</element-citation></ref><ref id="bib44"><label>44</label><element-citation publication-type="journal" id="sref44"><person-group person-group-type="author"><name><surname>Nagai</surname><given-names>T.</given-names></name><name><surname>Kusano</surname><given-names>H.</given-names></name><name><surname>Hamabe</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Newly developed mobile mass superimposed on mitral annulus calcification in patient with cerebral infarction: documentation of a unique embolic source</article-title><source>J&#x000a0;Cardiol Cases</source><volume>6</volume><year>2012</year><fpage>e13</fpage><lpage>e16</lpage><pub-id pub-id-type="pmid">30532937</pub-id>
</element-citation></ref><ref id="bib45"><label>45</label><element-citation publication-type="journal" id="sref45"><person-group person-group-type="author"><name><surname>Mohan</surname><given-names>J.C.</given-names></name><name><surname>Shukla</surname><given-names>M.</given-names></name><name><surname>Mohan</surname><given-names>V.</given-names></name><name><surname>Sethi</surname><given-names>A.</given-names></name></person-group><article-title>Mobile thrombus originating from densely calcified mitral annulus with cerebral embolism</article-title><source>Indian Heart J</source><volume>68</volume><issue>suppl 2</issue><year>2016</year><fpage>S131</fpage><lpage>S134</lpage><pub-id pub-id-type="pmid">27751264</pub-id>
</element-citation></ref><ref id="bib46"><label>46</label><element-citation publication-type="journal" id="sref46"><person-group person-group-type="author"><name><surname>Hadadi</surname><given-names>C.A.</given-names></name><name><surname>Manikat</surname><given-names>R.</given-names></name><name><surname>Elmi</surname><given-names>F.</given-names></name><name><surname>Shirani</surname><given-names>J.</given-names></name></person-group><article-title>Ruptured caseous mitral annular calcification presenting as a mobile mass</article-title><source>J&#x000a0;Am Coll Cardiol</source><volume>1</volume><year>2016</year><fpage>1200</fpage></element-citation></ref><ref id="bib47"><label>47</label><element-citation publication-type="journal" id="sref47"><person-group person-group-type="author"><name><surname>Singu</surname><given-names>T.</given-names></name><name><surname>Inatomi</surname><given-names>Y.</given-names></name><name><surname>Yonehara</surname><given-names>T.</given-names></name><name><surname>Ando</surname><given-names>Y.</given-names></name></person-group><article-title>Calcified amorphous tumor causing shower embolism to the brain: a case report with serial echocardiographic and neuroradiologic images and a review of the literature</article-title><source>J&#x000a0;Stroke Cerebrovasc Dis</source><volume>26</volume><year>2017</year><fpage>e85</fpage><lpage>e89</lpage><pub-id pub-id-type="pmid">28318955</pub-id>
</element-citation></ref><ref id="bib48"><label>48</label><element-citation publication-type="journal" id="sref48"><person-group person-group-type="author"><name><surname>Suma</surname><given-names>S.</given-names></name><name><surname>Molardi</surname><given-names>A.</given-names></name><name><surname>Vezzani</surname><given-names>A.</given-names></name><etal/></person-group><article-title>An unusual cause of ischaemic stroke: mobile thrombus on a caseous calcification of the mitral annulus</article-title><source>Eur Heart J Cardiovasc Imaging</source><volume>20</volume><issue>suppl 1</issue><year>2019</year><object-id pub-id-type="publisher-id">i743</object-id></element-citation></ref><ref id="bib49"><label>49</label><element-citation publication-type="journal" id="sref49"><person-group person-group-type="author"><name><surname>Chetrit</surname><given-names>M.</given-names></name><name><surname>Hassan</surname><given-names>O.A.</given-names></name><name><surname>Ho</surname><given-names>N.</given-names></name><name><surname>Collier</surname><given-names>P.</given-names></name><name><surname>Rodriguez</surname><given-names>L.L.</given-names></name></person-group><article-title>The "MAC" attack: when mitral annular calcification goes rogue! A case series of mobile mitral annular calcifications</article-title><source>Case</source><volume>4</volume><year>2020</year><fpage>467</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">33117951</pub-id>
</element-citation></ref><ref id="bib50"><label>50</label><element-citation publication-type="journal" id="sref50"><person-group person-group-type="author"><name><surname>Willner</surname><given-names>N.</given-names></name><name><surname>Burwash</surname><given-names>I.G.</given-names></name><name><surname>Beauchesne</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Natural history of mitral annular calcification and calcific mitral valve disease</article-title><source>J&#x000a0;Am Soc Echocardiogr</source><volume>35</volume><year>2022</year><fpage>925</fpage><lpage>932</lpage><pub-id pub-id-type="pmid">35618253</pub-id>
</element-citation></ref><ref id="bib51"><label>51</label><element-citation publication-type="journal" id="sref51"><person-group person-group-type="author"><name><surname>Kohsaka</surname><given-names>S.</given-names></name><name><surname>Jin</surname><given-names>Z.</given-names></name><name><surname>Rundek</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Impact of mitral annular calcification on cardiovascular events in a multiethnic community: the Northern Manhattan Study</article-title><source>JACC Cardiovasc Imaging</source><volume>1</volume><year>2008</year><fpage>617</fpage><lpage>623</lpage><pub-id pub-id-type="pmid">19356491</pub-id>
</element-citation></ref><ref id="bib52"><label>52</label><element-citation publication-type="journal" id="sref52"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>C.K.</given-names></name><name><surname>Thomson</surname><given-names>W.</given-names></name><name><surname>Ryschon</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Long-term follow-up of patients with echocardiographically detected mitral anular calcium and comparison with age- and sex-matched control subjects</article-title><source>Am J Cardiol</source><volume>63</volume><year>1989</year><fpage>465</fpage><lpage>470</lpage><pub-id pub-id-type="pmid">2916432</pub-id>
</element-citation></ref><ref id="bib53"><label>53</label><element-citation publication-type="journal" id="sref53"><person-group person-group-type="author"><name><surname>Aronow</surname><given-names>W.S.</given-names></name><name><surname>Koenigsberg</surname><given-names>M.</given-names></name><name><surname>Kronzon</surname><given-names>I.</given-names></name><name><surname>Gutstein</surname><given-names>H.</given-names></name></person-group><article-title>Association of mitral anular calcium with new thromboembolic stroke and cardiac events at 39-month follow-up in elderly patients</article-title><source>Am J Cardiol</source><volume>65</volume><year>1990</year><fpage>1511</fpage><lpage>1512</lpage><pub-id pub-id-type="pmid">2353658</pub-id>
</element-citation></ref><ref id="bib54"><label>54</label><element-citation publication-type="journal" id="sref54"><person-group person-group-type="author"><name><surname>Churchill</surname><given-names>T.W.</given-names></name><name><surname>Yucel</surname><given-names>E.</given-names></name><name><surname>Deferm</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Mitral valve dysfunction in patients with annular calcification: JACC review topic of the week</article-title><source>J&#x000a0;Am Coll Cardiol</source><volume>80</volume><year>2022</year><fpage>739</fpage><lpage>751</lpage><pub-id pub-id-type="pmid">35953139</pub-id>
</element-citation></ref><ref id="bib55"><label>55</label><element-citation publication-type="journal" id="sref55"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C.S.</given-names></name><name><surname>Schwartz</surname><given-names>I.S.</given-names></name><name><surname>Chapman</surname><given-names>I.</given-names></name></person-group><article-title>Calcification of the mitral annulus fibrosus with systemic embolization. A clinicopathologic study of 16 cases</article-title><source>Arch Pathol Lab Med</source><volume>111</volume><year>1987</year><fpage>411</fpage><lpage>414</lpage><pub-id pub-id-type="pmid">3566471</pub-id>
</element-citation></ref><ref id="bib56"><label>56</label><element-citation publication-type="journal" id="sref56"><person-group person-group-type="author"><name><surname>Otto</surname><given-names>C.M.</given-names></name><name><surname>Nishimura</surname><given-names>R.A.</given-names></name><name><surname>Bonow</surname><given-names>R.O.</given-names></name><etal/></person-group><article-title>2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</article-title><source>Circulation</source><volume>143</volume><year>2021</year><fpage>e72</fpage><lpage>e227</lpage><pub-id pub-id-type="pmid">33332150</pub-id>
</element-citation></ref><ref id="bib57"><label>57</label><element-citation publication-type="journal" id="sref57"><person-group person-group-type="author"><name><surname>El-Eshmawi</surname><given-names>A.</given-names></name><name><surname>Alexis</surname><given-names>S.L.</given-names></name><name><surname>Sengupta</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Surgical management of mitral annular calcification</article-title><source>Curr Opin Cardiol</source><volume>35</volume><year>2020</year><fpage>107</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">31895243</pub-id>
</element-citation></ref><ref id="bib58"><label>58</label><element-citation publication-type="journal" id="sref58"><person-group person-group-type="author"><name><surname>Edelman</surname><given-names>J.J.</given-names></name><name><surname>Badhwar</surname><given-names>V.</given-names></name><name><surname>Larbalestier</surname><given-names>R.</given-names></name><name><surname>Yadav</surname><given-names>P.</given-names></name><name><surname>Thourani</surname><given-names>V.H.</given-names></name></person-group><article-title>Contemporary surgical and transcatheter management of mitral annular calcification</article-title><source>Ann Thorac Surg</source><volume>111</volume><year>2021</year><fpage>390</fpage><lpage>397</lpage><pub-id pub-id-type="pmid">32798455</pub-id>
</element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><title>Supplementary Material</title><p id="p0160">
<supplementary-material content-type="local-data" id="mmc1"><caption><title>Supplemental Appendix</title></caption><media xlink:href="mmc1.pdf"/></supplementary-material>
</p></sec><ack id="ack0010"><sec id="sec4"><title>Ethics Statement</title><p id="p0140">The research reported has adhered to relevant ethical guidelines.</p></sec><sec id="sec5"><title>Patient Consent</title><p id="p0145">This article is a systemic review; therefore, the institutional review board did not require patient consent.</p></sec><sec id="sec6"><title>Funding Sources</title><p id="p0150">The authors have no funding sources to declare.</p></sec><sec id="sec7"><title>Disclosures</title><p id="p0155">W.T. is supported by the Melanie Munk Chair in Advanced Echocardiography Imaging. The other authors have no conflicts of interest to disclose.</p></sec></ack><fn-group><fn id="d36e721"><p id="ntpara0010a">See page 1546 for disclosure information.</p></fn><fn id="appsec2" fn-type="supplementary-material"><p id="p0165">To access the supplementary material accompanying this article, visit <italic>CJC Open</italic> at <ext-link ext-link-type="uri" xlink:href="https://www.cjcopen.ca/" id="intref0010">https://www.cjcopen.ca/</ext-link> and at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cjco.2024.09.001" id="intref0015">https://doi.org/10.1016/j.cjco.2024.09.001</ext-link>.</p></fn></fn-group></back></article>